209. The representative of the European Union said that it had been reported to his delegation that the WTO Workshop on Intellectual Property and Public Health had provided informative and helpful support to those Members seeking to utilize TRIPS flexibilities. Specific presentations on pricing had been particularly useful. They had clarified that there were many components relevant to the pricing of pharmaceuticals in addition to intellectual property. The inclusion of external speakers with various backgrounds had stimulated an open debate.
